Emopamil-Binding Protein Inhibitors for Treating Multiple Sclerosis.

Provided herein are novel emopamil-binding protein (EBP) inhibitors, their pharmaceutical compositions, the use of such compounds in treating multiple sclerosis, and processes for preparing such compounds.